ArticleNeuroradiology2020
Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
Article in Neuroradiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.
- Unique magnetic resonance spectroscopy profile of intracranial meningiomas compared to gliomas: a systematic review.Acta neurologica Belgica · 2023Pooled it
- Solitary fibrous tumor of the posterior fossa: a rare and atypical case report.International journal of surgery case reports · 2026Article
- Solitary Fibrous Tumours in the Central Nervous System and Their Clinical Mimickers: A Case Series.Cureus · 2026Article
- Multimodal MRI-based nomogram integrating clinical-radiological, radiomic, and habitat features to discriminate solitary fibrous tumors from atypical meningiomas.Scientific reports · 2026Article
- Article
- Solitary fibrous tumor: an updated review.Journal of pathology and translational medicine · 2026Article
- Multiparameter MRI-based automatic segmentation and diagnostic models for the differentiation of intracranial solitary fibrous tumors and meningiomas.Annals of medicine · 2025Article
- Distinguishing Intracranial Solitary Fibrous Tumors from Meningiomas: The Diagnostic Value of T1-Weighted MRI Signal Intensity and ADC Values.AJNR. American journal of neuroradiology · 2025Article
- Solitary fibrous tumors from A to Z: a pictorial review with radiologic-pathologic correlation.Insights into imaging · 2025Article
- Article
- Successful multimodal management of central nervous system solitary fibrous tumor: A case report.Radiology case reports · 2025Article
- Clinical outcomes of patients undergoing reoperation with solitary fibrous tumors/hemangiopericytomas and malignant progression of tumors.Neurosurgical review · 2024Article
- Solitary fibrous tumor of the brain: A report of 3 cases.Oncology letters · 2024Article
- Solitary Fibrous Tumor With an Acute Subdural Hematoma: A Case Report and Review of the Literature.Cureus · 2024Article
- Tumor-like Lesions in Primary Angiitis of the Central Nervous System: The Role of Magnetic Resonance Imaging in Differential Diagnosis.Diagnostics (Basel, Switzerland) · 2024Review
- Intracranial solitary fibrous tumor in a 15-year-old girl: illustrative case.Journal of neurosurgery. Case lessons · 2024Article
- Parasagittal meningeal hemangiopericytoma/solitary fibrous tumor: Two case reports and a literature review.Surgical neurology international · 2024Article
- Computational Fractal-Based Analysis of MR Susceptibility-Weighted Imaging (SWI) in Neuro-Oncology and Neurotraumatology.Advances in neurobiology · 2024Article
- Solitary Fibrous Tumor of the Central Nervous System: A Report of Two Cases with Emphasis on Diagnostic Pitfalls.Case reports in pathology · 2024Article
- Malignant intracranial solitary fibrous tumor: A case report and literature review.Radiology case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
purposeIntracranial solitary fibrous tumor/hemangiopericytoma (SFT/HPC) and meningioma are difficult to distinguish owing to their overlapping imaging manifestation on routine magnetic resonance imaging. The purpose of this study was to assess whether SFT/HPC can be differentiated from meningioma with diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI).
methodsWe retrospectively reviewed DWI, SWI, conventreional MR, and CT imaging features of 16 patients with SFT/HPC and 96 patients with meningioma. The apparent diffusion coefficient (ADC) value, normalized ADC (nADC) value, and degree of intratumoral susceptibility signal intensity (ITSS) were compared between SFT/HPCs and meningiomas using two-sample t tests, and among SFT/HPCs, low-grade and high-grade meningioma were tested using one-way analysis of variance (ANOVA). Receiver operating characteristic (ROC) curve and logistic regression analyses were performed to determine the differentiation capacity.
resultsThe ADC value, nADC value, and the degree of ITSS in SFT/HPC were significantly higher than those in low-grade and high-grade meningiomas (all p < 0.05). The threshold value of > 1.15 for nADC provided 75.00% sensitivity and 60.42% specificity for differentiating SFT/HPC from meningioma. Compared with nADC, the degree of ITSS had a moderate sensitivity (62.50%) and a higher specificity (85.42%) using the threshold value of > 1.00. Furthermore, combining DWI and SWI can achieve a relatively high differentiation capacity with a sensitivity of 81.25% and specificity of 78.12%.
conclusionsThe nADC ratios and ITSS are useful for differentiating SFT/HPC from meningioma. Combining ITSS and nADC value appears to be a promising option for differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.